BLOG/🇺🇸United States··daily

S&P 500 Healthcare Sector SEC Filings — January 14, 2026

USA S&P 500 Healthcare

9 high priority10 medium priority19 total filings analysed

Executive Summary

On January 15, 2026, 19 SEC 8-K filings surfaced in the S&P 500 Healthcare stream, but only Boston Scientific (twice) and Cingulate Inc. align directly with healthcare/pharma, revealing a mismatch with heavy financial sector noise; overarching neutral sentiment dominates with undisclosed details limiting insights. Cross-filing patterns show clusters of officer changes in financial firms and material agreements in select names, but no major healthcare catalysts emerge beyond Boston Scientific's Regulation FD disclosure and definitive agreement, suggesting subdued sector activity. Cumulative impact is low materiality overall, with one critical bearish delisting in financials; portfolio managers should prioritize monitoring healthcare pure-plays amid broader market filing surge.

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from January 13, 2026.

Investment Signals(4)

  • Boston Scientific dual filings (Reg FD + Material Definitive Agreement) signal potential strategic catalysts like M&A or updates [BULLISH] - Boston Scientific Corp

  • Cluster of neutral officer changes across financials indicates stable transitions without disruption [BULLISH] - Lakeland Financial, Pinnacle Financial, Citizens Financial, CNO Financial

  • Undisclosed financial results and Reg FD disclosures from Prudential and others [NEUTRAL] - Prudential Financial, Boston Scientific

  • Tectonic Financial delisting event erodes liquidity and investor confidence [BEARISH] - Tectonic Financial

Risk Flags(3)

  • (SYSTEMIC)

    Tectonic Financial delisting (Item 3.01) poses critical liquidity and valuation risks, with potential contagion to small-cap financials

  • (COMPANY-SPECIFIC)

    Multiple undisclosed Material Definitive Agreements (Boston Scientific, GBank, Matthews) hide unknown financial obligations or strategic shifts

  • Prevalent lack of details in 'Other Events' (Item 8.01 across 10+ filings) obscures potential hidden risks in operations or disclosures

Opportunities(3)

  • Boston Scientific's Material Definitive Agreement (AccNo

    0000947871-26-000037) could catalyze alpha via M&A in medical devices, monitor for pro forma financials

  • Reg FD disclosures (Boston Scientific, Prudential, GBank) offer early insight into Q4 results or guidance beats for long positions

  • Financial sector officer stability post-changes enables pair trades against underperformers like Tectonic

Sector Themes(3)

  • Undisclosed 'Other Events' and Reg FD clusters suggest coordinated earnings pre-announcements or updates, but sparse in healthcare vs. financials

  • Leadership turnover wave in financials (4 filings) correlates with neutral sentiment, signaling routine refresh without distress

  • Emerging material agreements (3 filings) hint at M&A/debt activity, with Boston Scientific as healthcare outlier amid financial dominance

Watch List(4)

  • 0000947871-26-000034 & -000037) - Dual filings may precede major announcements in med devices

  • 👁

    Tectonic Financial, Inc. - Delisting trajectory demands exit or short consideration

  • GBank Financial Holdings (AccNo
    👁

    0001193125-26-014215) - Multi-item filing with financial obligation risks spillover

  • 👁

    Financial officer changers (Lakeland, Pinnacle, Citizens, CNO) - Track for governance ripple effects

Filing Analyses(19)
Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 7/10

15-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002315, Size: 232 KB), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, dollar values, or quantitative results are provided in the filing summary. Sector is not specified.

NEWS CORP8-Kneutralmateriality 3/10

15-01-2026

News Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001564708-26-000010, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or contents of the financial statements/exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and quantitative data are NOT_DISCLOSED.

COMMUNITY FINANCIAL SYSTEM, INC.8-Kneutralmateriality 3/10

15-01-2026

COMMUNITY FINANCIAL SYSTEM, INC. filed a Form 8-K on January 15, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Accession Number: 0001104659-26-003879. File size: 1 MB.

BOSTON SCIENTIFIC CORP8-Kneutralmateriality 5/10

15-01-2026

Boston Scientific Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000947871-26-000034, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided in the filing summary. Sector not specified.

RAYMOND JAMES FINANCIAL INC8-Kneutralmateriality 2/10

15-01-2026

RAYMOND JAMES FINANCIAL INC filed an 8-K on January 15, 2026 (AccNo: 0000720005-26-000028, Size: 496 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

LAKELAND FINANCIAL CORP8-Kneutralmateriality 3/10

15-01-2026

Lakeland Financial Corp filed an 8-K on January 15, 2026 (AccNo: 0000721994-26-000007, Size: 5 MB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, reason for change, or compensation are disclosed in the provided filing summary.

Cingulate Inc.8-Kneutralmateriality 2/10

15-01-2026

Cingulate Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001493152-26-002417, Size: 282 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC.8-Kneutralmateriality 1/10

15-01-2026

FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC. filed a Form 8-K on January 15, 2026 (AccNo: 0001174947-26-000052, Size: 234 KB) reporting under Item 8.01 Other Events. No core event details, transaction values, financial impacts, or other specifics are disclosed in the provided filing summary. Sector is not specified.

PRUDENTIAL FINANCIAL INC8-Kneutralmateriality 5/10

15-01-2026

Prudential Financial Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001137774-26-000005, Size: 217 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). This is a financial results disclosure from the US market, sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

Bayview Acquisition Corp8-Kneutralmateriality 3/10

15-01-2026

Bayview Acquisition Corp filed an 8-K on January 15, 2026 (AccNo: 0001493152-26-002413, Size: 262 KB), disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. The filing is contextualized as a Merger/Acquisition event, but no specific deal structure, parties, valuation, or quantitative details are provided. Sector is not specified.

Pinnacle Financial Partners, Inc.8-Kneutralmateriality 5/10

15-01-2026

Pinnacle Financial Partners, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0002082866-26-000004, Size: 1 MB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are disclosed in the provided filing summary. Sector not specified.

InPoint Commercial Real Estate Income, Inc.8-Kneutralmateriality 3/10

15-01-2026

InPoint Commercial Real Estate Income, Inc. filed a Form 8-K on January 15, 2026, reporting under Item 8.01 Other Events. Accession Number: 0001193125-26-014119. File size: 225 KB. No specific details on the event, transaction values, or financial impacts disclosed.

CITIZENS FINANCIAL SERVICES INC8-Kneutralmateriality 3/10

15-01-2026

CITIZENS FINANCIAL SERVICES INC filed a Form 8-K on January 15, 2026 (AccNo: 0000739421-26-000005, Size: 147 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer position, individuals involved, reasons for change, or quantitative data are provided in the summary.

MATTHEWS INTERNATIONAL CORP8-Kneutralmateriality 8/10

15-01-2026

Matthews International Corp filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-014158, size 279 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction value, or financial impacts disclosed in the provided information. Sector is not specified.

COMMERCIAL METALS Co8-Kneutralmateriality 2/10

15-01-2026

COMMERCIAL METALS Co filed an 8-K on January 15, 2026 (AccNo: 0001193125-26-014157), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote results, or any quantitative data are disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure.

GBank Financial Holdings Inc.8-Kneutralmateriality 7/10

15-01-2026

GBank Financial Holdings Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001193125-26-014215, Size: 870 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.

BOSTON SCIENTIFIC CORP8-Kneutralmateriality 7/10

15-01-2026

Boston Scientific Corp filed a Form 8-K on January 15, 2026 (AccNo: 0000947871-26-000037, Size: 1 MB), reporting under Item 1.01 the entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial impacts are provided in the summary.

CNO Financial Group, Inc.8-Kneutralmateriality 3/10

15-01-2026

CNO Financial Group, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001224608-26-000005, Size: 542 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or compensation are provided in the summary. Sector is not specified.

Tectonic Financial, Inc.8-Kbearishmateriality 10/10

15-01-2026

Tectonic Financial, Inc. filed a Form 8-K on January 15, 2026 (AccNo: 0001185185-26-000175, Size: 238 KB), reporting a delisting event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing). Additional disclosures include Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on delisting reasons, financial impacts, transaction values, or sector are provided.

Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 19 filings

🇺🇸 More from United States

View all →
S&P 500 Healthcare Sector SEC Filings — January 14, 2026 | Gunpowder Blog